Michal Z. Haran

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma.

Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 30, 2023

Peripheral Blood Cell Mitochondrial Dysfunction in Myelodysplastic Syndrome Can Be Improved by a Combination of Coenzyme Q10 and Carnitine.

Peripheral Blood Cell Mitochondrial Dysfunction in Myelodysplastic Syndrome Can Be Improved by a Combination of Coenzyme Q10 and Carnitine.

Journal: Mediterranean journal of hematology and infectious diseases

Published: June 20, 2020

Acute steroid myopathy: a highly overlooked entity.

Acute steroid myopathy: a highly overlooked entity.

Journal: QJM : monthly journal of the Association of Physicians

Published: January 03, 2018

THE ROLE OF THE PLANT ARTEMISIA IN SURVIVAL AND INDUCTION OF APOPTOSIS OF B CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

THE ROLE OF THE PLANT ARTEMISIA IN SURVIVAL AND INDUCTION OF APOPTOSIS OF B CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Journal: Harefuah

Published: May 29, 2017

A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.

A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach.

Journal: British journal of haematology

Published: May 04, 2017

Loss of Muscle MTCH2 Increases Whole-Body Energy Utilization and Protects from Diet-Induced Obesity.

Loss of Muscle MTCH2 Increases Whole-Body Energy Utilization and Protects from Diet-Induced Obesity.

Journal: Cell reports

Published: February 02, 2017

Randomized Trial of Thymectomy in Myasthenia Gravis.

Randomized Trial of Thymectomy in Myasthenia Gravis.

Journal: The New England journal of medicine

Published: December 14, 2016

CD84 mediates CLL-microenvironment interactions.

CD84 mediates CLL-microenvironment interactions.

Journal: Oncogene

Published: December 28, 2015

Loss of Muscle MTCH2 Increases Whole-Body Energy Utilization and Protects from Diet-Induced Obesity.

Loss of Muscle MTCH2 Increases Whole-Body Energy Utilization and Protects from Diet-Induced Obesity.

Journal: Cell reports

Published: August 11, 2015

Balancing glycolysis and mitochondrial OXPHOS: lessons from the hematopoietic system and exercising muscles.

Balancing glycolysis and mitochondrial OXPHOS: lessons from the hematopoietic system and exercising muscles.

Journal: Mitochondrion

Published: May 17, 2014

SFEMG: the true value of the negative predictive value.

SFEMG: the true value of the negative predictive value.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published: January 09, 2014

CD84 is a survival receptor for CLL cells.

CD84 is a survival receptor for CLL cells.

Journal: Oncogene

Published: July 19, 2012

Showing 1-12 of 16

Last Updated: 09/26/2026